Genetically proxied PCSK9 inhibition provides indications of lower prostate cancer risk: a Mendelian randomization study. American Society of Human Genetics annual meeting 2022 (October 2022, Los ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback